Impact of mitral regurgitation in patients with worsening heart failure: insights from BIOSTAT‐CHF

Few data regarding the prevalence and prognostic impact of mitral regurgitation (MR) in patients with worsening chronic or new‐onset acute heart failure (HF) are available. We investigated the role of MR in the BIOlogy Study to TAilored Treatment in Chronic Heart Failure (BIOSTAT‐CHF).

[1]  M. Mack,et al.  3-Year Outcomes of Transcatheter Mitral Valve Repair in Patients With Heart Failure. , 2021, Journal of the American College of Cardiology.

[2]  G. Koch,et al.  Is acute heart failure a distinctive disorder? An analysis from BIOSTAT‐CHF , 2020, European journal of heart failure.

[3]  M. Vaduganathan,et al.  Prevalence and Prognostic Significance of Mitral Regurgitation in Acute Decompensated Heart Failure: The ARIC Study. , 2020, JACC. Heart failure.

[4]  M. Mack,et al.  NYHA Functional Classification and Outcomes After Transcatheter Mitral Valve Repair in Heart Failure: The COAPT Trial. , 2020, JACC. Cardiovascular interventions.

[5]  M. Guazzi,et al.  Pulmonary Hypertension in HFpEF and HFrEF: JACC Review Topic of the Week. , 2020, Journal of the American College of Cardiology.

[6]  R. Nishimura,et al.  Functional mitral regurgitation and left atrial myopathy in heart failure with preserved ejection fraction , 2020, European journal of heart failure.

[7]  M. Metra,et al.  Highlights in heart failure , 2019, ESC heart failure.

[8]  D. Maucort-Boulch,et al.  Percutaneous repair or medical treatment for secondary mitral regurgitation: outcomes at 2 years , 2019, European journal of heart failure.

[9]  Jeroen J. Bax,et al.  Concentric vs. eccentric remodelling in heart failure with reduced ejection fraction: clinical characteristics, pathophysiology and response to treatment , 2019, European journal of heart failure.

[10]  O. Alfieri,et al.  Treatment of functional mitral regurgitation in chronic heart failure: can we get a ‘proof of concept’ from the MITRA‐FR and COAPT trials? , 2019, European journal of heart failure.

[11]  K. Dickstein,et al.  Heart failure in the outpatient versus inpatient setting: findings from the BIOSTAT‐CHF study , 2018, European journal of heart failure.

[12]  T. Maruo,et al.  Dynamic severe mitral regurgitation on hospital arrival as prognostic predictor in patients hospitalized for acute decompensated heart failure. , 2018, International journal of cardiology.

[13]  M. Mack,et al.  Transcatheter Mitral‐Valve Repair in Patients with Heart Failure , 2018, The New England journal of medicine.

[14]  D. Maucort-Boulch,et al.  Percutaneous Repair or Medical Treatment for Secondary Mitral Regurgitation , 2018, The New England journal of medicine.

[15]  G. Filippatos,et al.  Comprehensive in‐hospital monitoring in acute heart failure: applications for clinical practice and future directions for research. A statement from the Acute Heart Failure Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) , 2018, European journal of heart failure.

[16]  Mikhail A. Dziadzko,et al.  Outcome and undertreatment of mitral regurgitation: a community cohort study , 2018, The Lancet.

[17]  J. Mascherbauer,et al.  Refining the prognostic impact of functional mitral regurgitation in chronic heart failure , 2017, European heart journal.

[18]  Roberto Ferrari,et al.  Epidemiology and one‐year outcomes in patients with chronic heart failure and preserved, mid‐range and reduced ejection fraction: an analysis of the ESC Heart Failure Long‐Term Registry , 2017, European journal of heart failure.

[19]  M. Metra,et al.  Heart failure , 2017, The Lancet.

[20]  A. Bayés‐Genís,et al.  Functional Mitral Regurgitation Predicts Short-Term Adverse Events in Patients With Acute Heart Failure and Reduced Left Ventricular Ejection Fraction. , 2017, The American journal of cardiology.

[21]  G. Filippatos,et al.  Clinical phenotypes and outcome of patients hospitalized for acute heart failure: the ESC Heart Failure Long‐Term Registry , 2017, European journal of heart failure.

[22]  N. Sato,et al.  Ischemic or Nonischemic Functional Mitral Regurgitation and Outcomes in Patients With Acute Decompensated Heart Failure With Preserved or Reduced Ejection Fraction. , 2017, The American journal of cardiology.

[23]  P. Ponikowski,et al.  Determinants and clinical outcome of uptitration of ACE-inhibitors and beta-blockers in patients with heart failure: a prospective European study , 2017, European heart journal.

[24]  P. Ponikowski,et al.  Development and validation of multivariable models to predict mortality and hospitalization in patients with heart failure , 2017, European journal of heart failure.

[25]  Volkmar Falk,et al.  2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure , 2016, Revista espanola de cardiologia.

[26]  G. Filippatos,et al.  European Society of Cardiology Heart Failure Long‐Term Registry (ESC‐HF‐LT): 1‐year follow‐up outcomes and differences across regions , 2016, European journal of heart failure.

[27]  P. Ponikowski,et al.  A systems BIOlogy Study to TAilored Treatment in Chronic Heart Failure: rationale, design, and baseline characteristics of BIOSTAT‐CHF , 2016, European journal of heart failure.

[28]  P. Boekstegers,et al.  One-year outcomes and predictors of mortality after MitraClip therapy in contemporary clinical practice: results from the German transcatheter mitral valve interventions registry , 2015, European heart journal.

[29]  T. Anzai,et al.  Prognostic Impact of Functional Mitral Regurgitation in Patients Admitted With Acute Decompensated Heart Failure. , 2016, Circulation journal : official journal of the Japanese Circulation Society.

[30]  D. Capodanno,et al.  Predictors of clinical outcomes after edge-to-edge percutaneous mitral valve repair. , 2015, American heart journal.

[31]  M. Mack,et al.  Secondary mitral regurgitation in heart failure: pathophysiology, prognosis, and therapeutic considerations. , 2015, Journal of the American College of Cardiology.

[32]  J. Zamorano,et al.  Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European Association of Cardiovascular Imaging. , 2013, European heart journal cardiovascular Imaging.

[33]  L. Tavazzi,et al.  Multicenter Prospective Observational Study on Acute and Chronic Heart FailureClinical Perspective , 2013 .

[34]  Robert N. Doughty,et al.  The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis. , 2011, European heart journal.

[35]  M. Cheitlin.  Independent prognostic value of functional mitral regurgitation in patients with heart failure. A quantitative analysis of 1256 patients with ischaemic and non-ischaemic dilated cardiomyopathy , 2012 .

[36]  L. Køber,et al.  The relationship between mitral regurgitation and ejection fraction as predictors for the prognosis of patients with heart failure , 2011, European journal of heart failure.

[37]  M. Enriquez-Sarano,et al.  Independent prognostic value of functional mitral regurgitation in patients with heart failure. A quantitative analysis of 1256 patients with ischaemic and non-ischaemic dilated cardiomyopathy , 2011, Heart.

[38]  A. Branzi,et al.  Prognostic implications of functional mitral regurgitation according to the severity of the underlying chronic heart failure: a long‐term outcome study , 2010, European journal of heart failure.

[39]  S. Solomon,et al.  Mitral regurgitation in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: prognostic significance and relation to ventricular size and function. , 2005, European heart journal.

[40]  N Freemantle,et al.  The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. , 2003, European heart journal.

[41]  C. O'connor,et al.  Relation of frequency and severity of mitral regurgitation to survival among patients with left ventricular systolic dysfunction and heart failure. , 2003, The American journal of cardiology.

[42]  K. Bailey,et al.  Ischemic Mitral Regurgitation: Long-Term Outcome and Prognostic Implications With Quantitative Doppler Assessment , 2001, Circulation.